.After antibody-drug conjugate (ADC) specialist Seagen was offered to Pfizer in 2013 for a massive $...
.On the heels of a phase 3 gain that stopped working to excite clients, Ironwood Pharmaceuticals is ...
.Don't quit Monte Rosa Therapeutics right now. The Boston-based biotech is actually enjoying after a...
.Welcome to today's Chutes & Ladders, our summary of notable management hirings, shootings and re...
.Celebrating his company's upsized going public (IPO), Septerna CEO Jeffrey Finer rang the position ...
.AbbVie has actually come back to the resource of its antipsychotic goliath Vraylar searching for an...
.GenSight Biologics is actually full weeks far from losing cash. Once more. The biotech merely has e...
.Monopar Therapeutics is actually recuperating a medicine coming from the dump of AstraZeneca's unus...
.With brand-new information out on Arcus Biosciences' experimental HIF-2a prevention, one group of a...
.After developing a gene treatment collaboration with Dyno Rehabs in 2020, Roche is back for more.In...